HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NGB 2904

a dopamine D3 receptor antagonist; structure in first source
Also Known As:
N-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyl)-3-fluorenylcarboxamide; NGB-2904
Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Newman, Amy Hauck: 2 articles (05/2007 - 07/2006)
2. Gardner, Eliot L: 2 articles (01/2007 - 07/2006)
3. Xi, Zheng-Xiong: 2 articles (01/2007 - 07/2006)
4. Banasikowski, Tomek J: 1 article (10/2012)
5. Beninger, Richard J: 1 article (10/2012)
6. Nader, Michael A: 1 article (05/2007)
7. Claytor, Renee: 1 article (05/2007)
8. Ross, Jason T: 1 article (05/2007)
9. Martelle, Jennifer L: 1 article (05/2007)
10. Reboussin, Beth A: 1 article (05/2007)

Related Diseases

1. Cocaine-Related Disorders (Cocaine Addiction)
2. Substance-Related Disorders (Drug Abuse)
3. Catalepsy

Related Drugs and Biologics

1. Dopamine D3 Receptors
2. N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamide
3. fluorene
4. benzamide
5. Haloperidol (Haldol)
6. Dopamine (Intropin)
7. Cocaine (Cocaine HCl)
8. nafadotride

Related Therapies and Procedures

1. Self Administration (Administration, Self)